BioSpace News Archive

Business

Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2021 after market close on Monday, August 9, 2021 at 4:30 PM Eastern Time

July 12, 2021
·
1 min read
Biotech Beach

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - July 12, 2021

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, announced the issuance of an equity inducement award as required by the Nasdaq Stock Market Rules.

July 12, 2021
·
4 min read
Business

Envista Schedules Second Quarter 2021 Earnings Call

Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its second quarter 2021 on Tuesday, August 3, 2021.

July 12, 2021
·
2 min read
Biotech Bay

Arcus Biosciences Announces New Employment Inducement Grants - July 12, 2021

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted seven new employees options to purchase a total of 77,800 shares of the Company’s common stock at an exercise price per share of $28.75, which was the closing price on July 8, 2021.

July 12, 2021
·
2 min read
Business

Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results

Simulations Plus, Inc., a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, reported financial results for its third quarter of fiscal 2021, ended May 31, 2021.

July 12, 2021
·
7 min read
Policy

PLx Pharma Inc.’s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August

PLx Pharma Inc. announced that three stock-keeping units of VAZALORE, the first and only U.S. Food and Drug Administration approved liquid-filled aspirin capsules, will be available in over 4,500 Walmart stores across the United States in mid-August.

July 12, 2021
·
2 min read
Deals

Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock

Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000 shares of its common stock.

July 12, 2021
·
3 min read
Advancement in Molecular Diagnostic Tools to Propel the Growth of the Point of Care Molecular Diagnostics Market

The molecular diagnostic field has substantially decreased the time required to identify infectious agents and their antimicrobial resistance.

July 12, 2021
·
3 min read
Biotech Bay

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 12, 2021

Mirum Pharmaceuticals, Inc. announced that on July 12, 2021, the Compensation Committee of Mirum’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 146,400 shares of common stock to 10 new employees under Mirum’s 2020 Inducement Plan.

July 12, 2021
·
2 min read
Business

Baxter Declares Quarterly Dividend - July 12, 2021

Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock.

July 12, 2021
·
1 min read